• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变的自动筛查——一项系统综述

Automated Screening for Diabetic Retinopathy - A Systematic Review.

作者信息

Nørgaard Mads Fonager, Grauslund Jakob

机构信息

Department of Ophthalmology, Odense University Hospital, Odense, Denmark.

Research Unit of Ophthalmology, Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

出版信息

Ophthalmic Res. 2018;60(1):9-17. doi: 10.1159/000486284. Epub 2018 Jan 16.

DOI:10.1159/000486284
PMID:29339646
Abstract

PURPOSE

Worldwide ophthalmologists are challenged by the rapid rise in the prevalence of diabetes. Diabetic retinopathy (DR) is the most common complication in diabetes, and possible consequences range from mild visual impairment to blindness. Repetitive screening for DR is cost-effective, but it is also a costly and strenuous affair. Several studies have examined the application of automated image analysis to solve this problem. Large populations are needed to assess the efficacy of such programs, and a standardized and rigorous methodology is important to give an indication of system performance in actual clinical settings.

METHODS

In a systematic review, we aimed to identify studies with methodology and design that are similar or replicate actual screening scenarios. A total of 1,231 publications were identified through PubMed, Cochrane Library, and Embase searches. Three manual search strategies were carried out to identify publications missed in the primary search. Four levels of screening identified 7 studies applicable for inclusion.

RESULTS

Seven studies were included. The detection of DR had high sensitivities (87.0-95.2%) but lower specificities (49.6-68.8%). False-negative results were related to mild DR with a low risk of progression within 1 year. Several studies reported missed cases of diabetic macular edema. A meta-analysis was not conducted as studies were not suitable for direct comparison or statistical analysis.

CONCLUSION

The study demonstrates that despite limited specificity, automated retinal image analysis may potentially be valuable in different DR screening scenarios with a relatively high sensitivity and a substantial workload reduction.

摘要

目的

全球眼科医生面临着糖尿病患病率迅速上升的挑战。糖尿病视网膜病变(DR)是糖尿病最常见的并发症,其可能后果从轻度视力损害到失明不等。对DR进行重复筛查具有成本效益,但也是一项昂贵且费力的工作。多项研究探讨了应用自动图像分析来解决这一问题。需要大量人群来评估此类程序的有效性,并且标准化且严格的方法对于表明系统在实际临床环境中的性能很重要。

方法

在一项系统评价中,我们旨在识别方法和设计与实际筛查场景相似或重复的研究。通过PubMed、Cochrane图书馆和Embase检索共识别出1231篇出版物。开展了三种手动检索策略以识别在初步检索中遗漏的出版物。四级筛选确定了7项适用于纳入的研究。

结果

纳入了7项研究。DR检测具有较高的敏感性(87.0 - 95.2%)但特异性较低(49.6 - 68.8%)。假阴性结果与1年内进展风险较低的轻度DR有关。多项研究报告了糖尿病黄斑水肿的漏诊病例。由于研究不适合直接比较或统计分析,因此未进行荟萃分析。

结论

该研究表明,尽管特异性有限,但自动视网膜图像分析在不同的DR筛查场景中可能具有潜在价值,具有相对较高的敏感性且可大幅减少工作量。

相似文献

1
Automated Screening for Diabetic Retinopathy - A Systematic Review.糖尿病视网膜病变的自动筛查——一项系统综述
Ophthalmic Res. 2018;60(1):9-17. doi: 10.1159/000486284. Epub 2018 Jan 16.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Interventions to increase attendance for diabetic retinopathy screening.提高糖尿病视网膜病变筛查参与率的干预措施。
Cochrane Database Syst Rev. 2018 Jan 15;1(1):CD012054. doi: 10.1002/14651858.CD012054.pub2.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
9
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
10
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.

引用本文的文献

1
Diagnostic utility of artificial intelligence software through non-mydriatic digital retinography in the screening of diabetic retinopathy: an overview of reviews.人工智能软件通过免散瞳数字视网膜成像技术在糖尿病视网膜病变筛查中的诊断效用:综述概述
Eye (Lond). 2025 Apr 29. doi: 10.1038/s41433-025-03809-y.
2
Screening for diabetic retinopathy with artificial intelligence: a real world evaluation.利用人工智能筛查糖尿病视网膜病变:一项真实世界评估。
Acta Diabetol. 2024 Dec;61(12):1603-1607. doi: 10.1007/s00592-024-02333-x. Epub 2024 Jul 12.
3
How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan?
人工智能在日本糖尿病视网膜病变筛查中如何有效实施?
Medicina (Kaunas). 2024 Jan 30;60(2):243. doi: 10.3390/medicina60020243.
4
Fine-grained attention & knowledge-based collaborative network for diabetic retinopathy grading.用于糖尿病视网膜病变分级的细粒度注意力与基于知识的协作网络
Heliyon. 2023 Jun 16;9(7):e17217. doi: 10.1016/j.heliyon.2023.e17217. eCollection 2023 Jul.
5
Patient referral flow between physician and ophthalmologist visits for diabetic retinopathy screening among Japanese patients with diabetes: A retrospective cross-sectional cohort study using the National Database.利用国家数据库对日本糖尿病患者的糖尿病视网膜病变筛查中,医生和眼科医生就诊之间的患者转诊流程:一项回顾性横断面队列研究。
J Diabetes Investig. 2023 Jul;14(7):883-892. doi: 10.1111/jdi.14018. Epub 2023 May 2.
6
Automated Systems for Calculating Arteriovenous Ratio in Retinographies: A Scoping Review.视网膜造影术中计算动静脉比率的自动化系统:一项范围综述
Diagnostics (Basel). 2022 Nov 18;12(11):2865. doi: 10.3390/diagnostics12112865.
7
A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening program.新西兰筛查项目中使用 THEIA™ 检测糖尿病视网膜病变(DR)和糖尿病性黄斑水肿(DMO)的多中心前瞻性评估。
Eye (Lond). 2023 Jun;37(8):1683-1689. doi: 10.1038/s41433-022-02217-w. Epub 2022 Sep 3.
8
Automated image curation in diabetic retinopathy screening using deep learning.基于深度学习的糖尿病视网膜病变筛查中的自动化图像整理。
Sci Rep. 2022 Jul 1;12(1):11196. doi: 10.1038/s41598-022-15491-1.
9
Diabetic retinopathy screening in the emerging era of artificial intelligence.人工智能新兴时代的糖尿病视网膜病变筛查。
Diabetologia. 2022 Sep;65(9):1415-1423. doi: 10.1007/s00125-022-05727-0. Epub 2022 May 31.
10
Screening Diabetic Retinopathy Using an Automated Retinal Image Analysis System in Independent and Assistive Use Cases in Mexico: Randomized Controlled Trial.在墨西哥独立和辅助使用案例中使用自动视网膜图像分析系统筛查糖尿病视网膜病变:随机对照试验
JMIR Form Res. 2021 Aug 26;5(8):e25290. doi: 10.2196/25290.